Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemia

Clin Cancer Res. 2010 Jan 15;16(2):373-5. doi: 10.1158/1078-0432.CCR-09-2948. Epub 2010 Jan 12.

Abstract

Increasing evidence supports the prognostic relevance of specific immunoglobulin heavy chain variable (IGHV) genes or stereotyped B-cell receptors (BCR) in chronic lymphocytic leukemia (CLL). The clonotypic BCRs differ in their specificity and affinity toward classical antigens and/or superantigens. The BCR-triggered mechanisms are distinct but could explain in part the different clinical behavior among CLL subgroups.

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Expression Regulation, Leukemic
  • Gene Rearrangement / genetics*
  • Humans
  • Immunoglobulin Class Switching / genetics
  • Immunoglobulin Heavy Chains / genetics*
  • Immunoglobulin Heavy Chains / immunology
  • Immunoglobulin Variable Region / genetics*
  • Immunoglobulin Variable Region / immunology
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Lymphocyte Activation / genetics
  • Models, Biological
  • Receptors, Antigen, B-Cell / genetics
  • Receptors, Antigen, B-Cell / immunology
  • Receptors, Antigen, B-Cell / metabolism
  • Superantigens / immunology*

Substances

  • Immunoglobulin Heavy Chains
  • Immunoglobulin Variable Region
  • Receptors, Antigen, B-Cell
  • Superantigens